Page last updated: 2024-09-03

clofarabine and Sarcoma, Ewing

clofarabine has been researched along with Sarcoma, Ewing in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (33.33)24.3611
2020's2 (66.67)2.80

Authors

AuthorsStudies
Atasoy, S; Balaraman, K; Deniz, E; Molotkova, A; Nelson, E; Pilicer, SL; Sevim, H; Tiwari, PB; Üren, A; Wolf, C1
Çelik, H; Ceyhan, CS; Düşünceli, L; Graham, GT; Molotkova, A; Nakazawa, K; Petro, JR; Sevim, H; Toretsky, JA; Üren, A1
Allegakoen, DV; Çelik, H; Conn, EJ; Flashner, B; Gelmez, E; Han, J; Harris, BT; Hayran, M; Hour, S; Kayraklıoğlu, N; Manara, MC; Oktay, L; Petro, JR; Sciandra, M; Scotlandi, K; Tiwari, PB; Toretsky, JA; Üren, A1

Other Studies

3 other study(ies) available for clofarabine and Sarcoma, Ewing

ArticleYear
Design, synthesis and biological evaluation of Nucleosidic CD99 inhibitors that selectively reduce Ewing sarcoma viability.
    European journal of medicinal chemistry, 2023, May-05, Volume: 251

    Topics: 12E7 Antigen; Cell Adhesion Molecules; Child; Cladribine; Clofarabine; DNA; Humans; Sarcoma, Ewing

2023
Clofarabine induces ERK/MSK/CREB activation through inhibiting CD99 on Ewing sarcoma cells.
    PloS one, 2021, Volume: 16, Issue:6

    Topics: 12E7 Antigen; Antimetabolites, Antineoplastic; Blotting, Western; Cell Line, Tumor; Clofarabine; CREB-Binding Protein; Humans; MAP Kinase Signaling System; Phosphorylation; Ribosomal Protein S6 Kinases, 90-kDa; Sarcoma, Ewing; Signal Transduction

2021
Clofarabine inhibits Ewing sarcoma growth through a novel molecular mechanism involving direct binding to CD99.
    Oncogene, 2018, Volume: 37, Issue:16

    Topics: 12E7 Antigen; A549 Cells; Animals; Bone Neoplasms; Cell Line, Tumor; Cell Proliferation; Clofarabine; Female; Humans; MCF-7 Cells; Mice; Mice, SCID; Protein Binding; Sarcoma, Ewing; Signal Transduction; Small Molecule Libraries; Xenograft Model Antitumor Assays

2018